Xtant Medical Holdings (XTNT) Common Equity (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Common Equity data on file, last reported at $51.0 million in Q4 2025.

• On a quarterly basis, Common Equity rose 18.6% year-over-year to $51.0 million in Q4 2025; TTM through Dec 2025 was $51.0 million, a 18.6% increase from a year earlier, with the FY2025 full-year figure at $51.0 million, up 18.6% from the prior year.
• Common Equity for Q4 2025 stood at $51.0 million, up from $50.4 million in the prior quarter.
• Over the last five years, Common Equity for XTNT reached as high as $54.7 million in Q3 2023 and fell as low as $28.1 million in Q2 2022.
• Historically, Common Equity has averaged $40.0 million across 5 years, with a median of $38.6 million in 2022.
• On a YoY basis, Common Equity climbed as much as 172.31% in 2021 and fell as far as 31.98% in 2021.
• Year by year, Common Equity stood at $30.9 million in 2021, then gained by 10.65% to $34.2 million in 2022, then surged by 50.27% to $51.3 million in 2023, then slipped by 16.33% to $43.0 million in 2024, then advanced by 18.6% to $51.0 million in 2025.
• Per Business Quant data, the three most recent Common Equity figures were $51.0 million in Q4 2025, $50.4 million in Q3 2025, and $48.5 million in Q2 2025.